Euroapi S.A. (EPA:EAPI)

Market Cap	201.66M -31.9%
Revenue (ttm)	882.80M -9.1%
Net Income	-124.30M
EPS	-1.31
Shares Out	95.21M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,693
Average Volume	211,967
Open	2.102
Previous Close	2.118
Day's Range	2.094 - 2.114
52-Week Range	2.066 - 3.572
Beta	0.63
RSI	36.98
Earnings Date	Mar 3, 2026

About Euroapi

Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use in France, Europe, Rest of Europe, North America, the Asia Pacific, and internationally. The company offers contract development manufacturing organization for different classes of tides that uses solid phase chemistry; particle engineering; microbial fermentation; small molecules synthesis; prostaglandins; steroids and hormones; and opiates and controlled substances....

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2020
• Employees: 3,187
• Stock Exchange: Euronext Paris
• Ticker Symbol: EAPI

Financial Performance

In 2024, Euroapi's revenue was 919.20 million, a decrease of -9.79% compared to the previous year's 1.02 billion. Losses were -130.60 million, -31.15% less than in 2023.